Diabetes Mellitus Hastalarının Pandemi Öncesi ve Pandemi Sırasında Glisemik Kontrolüne Genel Bir Bakış

Öz

Amaç: Diabetes Mellitus kan glukozu yüksekliği ile seyreden, dünya üzerinde milyonlarca insanı etkileyen ve komplikasyonları olan kronik bir hastalıktır. Pandemi döneminde birçok faktörün hastaların glisemik kontrolünü olumsuz yönde etkilediğini düşünmekteyiz. Bu çalışma ile İncesu Devlet Hastanesi aile hekimliği polikliniğine başvuran hastaların pandemi öncesi ve esnasında glisemik kontrollerini karşılaştırmayı amaçladık. Materyal ve Metot: Aile hekimliği polikliniğine başvuran toplam 203 hastanın demografik verileri, HbA1c değerleri, iki başvuru arasında geçen süreleri, beden kitle indeksleri değerlendirildi. Verilerin analizinde frekans, ortalama ve standart sapma değerleri kullanıldı. Bulgular: Pandemi öncesi ve esnasında HbA1c değeri bakılan toplam 203 hasta dâhil edildi. Hastaların yaş ortalaması 60,87±15,24 idi. Çalışmaya dâhil edilen hastaların %52,7’si kadındı. Pandemi öncesi bakılan HbA1c değerlerinin ortalaması, pandemi esnasında bakılan HbA1c değerlerinin ortalamasından düşüktü. Sonuç: Uygulanan tedbirler kapsamında; evde geçirilen sürenin artması, fiziksel egzersizin azalması, zorlayıcı psikolojik faktörlerin olması, hastaların glisemik kontrolünün bozulmasına sebep olduğu düşünülmüştür. Kronik hastalıkları bulunan kişilerin sağlık otoriterleri tarafından desteklenmesi sorunların çözümünde yardımcı olabilir.

Anahtar Kelimeler

• SARS- CoV-2
• Diabetes mellitus
• pandemi
• HbA1c

An Overview of the Glycemic Control of Diabetes Mellitus Patients Before and During the Pandemic

Öz

Aim: Diabetes Mellitus is a chronic disorder characterized by high blood glucose and affects millions of people around the world with its complications. We believe that several factors during the pandemic have negatively affected the glycemic control of the patients. This study aimed to compare the glycemic controls of the patients admitted to the family health clinic of Incesu State Hospital before and during the pandemic. Material and Methods: Demographic data, HbA1c values, durations between the two admissions, and body mass indices of a total of 203 patients admitted to the family medicine clinic were assessed. Frequency, mean and standard deviation values were used in the analysis of the data. Results: A total of 203 patients who had HbA1c test before and during the pandemic were included in the study. Mean age of the patients was 60.87±15.24. Of the patients included in the study, 52.7% were female. Mean HbA1c value tested before the pandemic was lower than the mean HbA1c value tested during the pandemic. Conclusion: Increase in time spent at home, decrease in physical exercises and the presence of forcing psychological factors as a result of the measures taken have caused the glycemic control of the patients to impair. The individuals with chronic diseases can be supported by health authorities, which may help to solve the problems.

Anahtar Kelimeler

• SARS- CoV-2
• Diabetes Mellitus
• Pandemi
• HbA1c

Kaynakça

1. 1. World Health Organization Coronavirus (COVID-19) Situtiation Report. https://apps.who.int/iris/handle/10665/332089. Erişim Tarihi: 03 Mayıs 2021
2. 2. Cuschieri S, Grech S. COVID-19 and diabetes: The why, the what and the how. J Diabetes Complications. 2020;34(9):107637. (doi: 10.1016/j.jdiacomp.2020.107637).
3. 3. Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications. 2010;24(2):84-9. (doi: 10.1016/j.jdiacomp.2008.12.008).
4. 4. Hartz A, Kent S, James P, Xu Y, Kelly M, Daly J. Factors that influence improvement for patients with poorly controlled type 2 diabetes. Diabetes Res Clin Pract. 2006;74(3):227-32. (doi: 10.1016/j.diabres.2006.03.023).
5. 5. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. (doi: 10.1001/jama.2020.1585).
6. 6. Guthrie RA, Guthrie DW. Pathophysiology of diabetes mellitus. Crit Care Nurs Q. 2004;27(2):113-25. (doi: 10.1097/00002727-200404000-00003).
7. 7. Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-8. (doi: 10.1007/s00392-020-01626-9).
8. 8. Singh AK, Khunti K. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review. Diabetes Res Clin Pract. 2020;165:108266. (doi: 10.1016/j.diabres.2020.108266).

9. 9. Aslaner H, Aslaner HA, Gökçek MB, Benli AR, Yıldız O. The Effect of Chronic Diseases, Age and Gender on Morbidity and Mortality of COVID-19 Infection. Iran J Public Health. 2021;50(4):721-7. (doi: 10.18502/ijph.v50i4.5996).
10. 10. Önmez A, Gamsızkan Z, Özdemir Ş, et al. The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey. Diabetes Metab Syndr. 2020;14(6):1963-6. (doi: 10.1016/j.dsx.2020.10.007).
11. 11. Fernández E, Cortazar A, Bellido V. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract. 2020;166:108348. (doi: 10.1016/j.diabres.2020.108348).
12. 12. Ghesquière L, Garabedian C, Drumez E, et al. Effects of COVID-19 pandemic lockdown on gestational diabetes mellitus: A retrospective study. Diabetes Metab. 2021;47(2):101201. (doi: 10.1016/j.diabet.2020.09.008).
13. 13. Tanji Y, Sawada S, Watanabe T, Mita T, Kobayashi Y, Murakami T, Metoki H, Akai H. Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown. Diabetes Res Clin Pract. 2021;176:108840. (doi: 10.1016/j.diabres.2021.108840).
14. 14. Diabetes Mellitus Ve Komplikasyonlarının Tanı, Tedavi Ve İzlem Kılavuzu 2020. https://temd.org.tr/admin/uploads/tbl_kilavuz/20200625154506-2020tbl_kilavuz86bf012d90.pdf. Erişim Tarihi: 01 Mayıs 2021.
15. 15. Zeybek Z, Bozkurt Y, Aşkın R. Covid-19 pandemisi: Psikolojik etkileri ve terapötik müdahaleler. İstanbul Ticaret Üniversitesi Sosyal Bilimler Dergisi, 2020, 19.37: 304-18.
16. 16. Naja F, Hamadeh R. Nutrition amid the COVID-19 pandemic: a multi-level framework for action. Eur J Clin Nutr. 2020;74(8):1117-1121. (doi: 10.1038/s41430-020-0634-3).
17. 17. Kim TH, Park Y, Myung J, Han E. Food price trends in South Korea through time series analysis. Public Health. 2018;165:67-73. (doi: 10.1016/j.puhe.2018.09.007).
18. 18. Munekawa C, Hosomi Y, Hashimoto Y, et al. Effect of coronavirus disease 2019 pandemic on the lifestyle and glycemic control in patients with type 2 diabetes: a cross-section and retrospective cohort study. Endocr J. 2021 Feb 28;68(2):201-210. (doi: 10.1507/endocrj.EJ20-0426).
19. 19. Lim S, Shin SM, Nam GE, Jung CH, Koo BK. Proper Management of People with Obesity during the COVID-19 Pandemic. J Obes Metab Syndr. 2020;29(2):84-98. (doi: 10.7570/jomes20056).
20. 20. Khan MA, Moverley Smith JE. "Covibesity," a new pandemic. Obes Med. 2020;19:100282. (doi: 10.1016/j.obmed.2020.100282).
21. 21. Tornese G, Ceconi V, Monasta L, Carletti C, Faleschini E, Barbi E. Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Quarantine and the Role of In-Home Physical Activity. Diabetes Technol Ther. 2020;22(6):462-7. (doi: 10.1089/dia.2020.0169).
22. 22. Çakır S, Sağlam H, Özgür T, Erdal E, Tarım, Ö. Tip 1 diyabetli çocuklarda glisemik kontrolü etkileyen faktörler. Güncel Pediatri. 2010;8(2), 7-19.
23. 23. Solomou I, Constantinidou F. Prevalence and Predictors of Anxiety and Depression Symptoms during the COVID-19 Pandemic and Compliance with Precautionary Measures: Age and Sex Matter. Int J Environ Res Public Health. 2020;17(14):4924. (doi: 10.3390/ijerph17144924).
24. 24. Cullen W, Gulati G, Kelly BD. Mental health in the COVID-19 pandemic. QJM. 2020;113(5):311-2. (doi: 10.1093/qjmed/hcaa110).
25. 25. Ünsal Avdal E. (2010). Web tabanlı verilen diyabet eğitiminin bakım sonuçlarına etkisi randomize kontrollü çalışma. Ph.D. Thesis, DEÜ Sağlık Bilimleri Enstitüsü, İç Hastalıkları Hemşireliği Anabilim Dalı, İzmir, 2010;60-2.
26. 26. Wang A, Zhao W, Xu Z, Gu J. Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract. 2020;162:108118. (doi: 10.1016/j.diabres.2020.108118).
27. 27. Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020;14(3):211-212. (doi: 10.1016/j.dsx.2020.03.002).